Top Markets
#1 ADO Protocol ADO Protocol +336.48%
#2 GoPlus Security GoPlus Security +50.52%
#3 Starpower Starpower +36.17%
#4 Fake World Assets Fake World Assets +29.96%
#5 FGRS (Figure Tokenized Stock) FGRS (Figure Tokenized Stock) +26.56%
#6 GAIB AID GAIB AID +24.67%
#7 Nockchain Nockchain +22.31%
#8 The Black Bull The Black Bull +18.45%
#9 OpenEden OpenEden +14.53%
#10 Tutorial Tutorial +12.76%
Coin of the day
ADO Protocol ADO Protocol
सेटिंग्स
भाषा
हिन्दी
मुद्रा
USD
थीम
Traws Pharma, Inc. Traws Pharma, Inc.

Traws Pharma, Inc.

TRAW
शेयरों में रैंक #33205
Traws Pharma, Inc., a biopharmaceutical firm in the clinical development stage,... Traws Pharma, Inc., a biopharmaceutical firm in the clinical development stage, is dedicated to creating novel small-molecule medications delivered orally to combat both respiratory viral infections and various forms of cancer. Its pipeline includes experimental treatments specifically designed to overcome drug resistance in influenza and COVID-19. These promising candidates include TRX01 (travatrelvir), an Mpro/3CL inhibitor currently undergoing development for COVID-19, and TRX100 (viroxavir), an endonuclease inhibitor advancing through trials for pandemic influenza. Additionally, Traws Pharma's oncology portfolio features narazaciclib, a multi-kinase CDK4/6 inhibitor. This compound is presently in Phase 1/2 clinical trials in cancer patients, being evaluated both independently and in conjunction with letrozole, with the goal of establishing the recommended Phase 2 dosage for future work in endometrial cancer. The company is also investigating oral rigosertib, exploring its potential as a standalone therapy or in combination regimens across diverse cancer types. Originally established in 1998 as Onconova Therapeutics, Inc., the company officially adopted its current name, Traws Pharma, Inc., in April 2024. Its corporate headquarters are located in Newtown, Pennsylvania.
शेयर मूल्य
$0.55
मार्केट कैप
$8.38M
बदलाव (1 दिन)
-3.68%
बदलाव (1 वर्ष)
-63.58%
देश
US
व्यापार Traws Pharma, Inc. (TRAW)

श्रेणी

Healthcare
Traws Pharma, Inc. (TRAW) के लिए स्टॉक मूल्य इतिहास
दिन का सबसे उच्च समापन मूल्य: $0.55 (2026-08-01 को)

दिन का सबसे निम्न समापन मूल्य: $1.18M (2013-07-01 को)
Traws Pharma, Inc. के स्टॉक मूल्य का इतिहास 2013 से 2026 तक
प्रत्येक वर्ष के अंत में स्टॉक मूल्य प्रदर्शन
वर्ष प्रदर्शन
2026 (TTM) -7.87%
2025 -73.19%
2024 -62.45%
2023 -1.12%
2022 -73.33%
2021 -51.96%
2020 16.11%
2019 -88.57%
2018 -87.09%
2017 -39.73%
2016 -78.39%
2015 -71.56%
2014 -71.82%
2013 0.00%
समान कंपनियों या प्रतिस्पर्धियों के स्टॉक मूल्य
कंपनी स्टॉक मूल्य परिवर्तन 1व% देश
Vertex Pharmaceuticals Incorporated Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
VRTX.US
 $513.32 30.69%
US
Argenx SE Argenx SE
Argenx SE
ARGX.US
 $988.91 51.25%
NL
Lonza Group AG Lonza Group AG
Lonza Group AG
LONN.SW
 $736.38 7.15%
CH
Samsung Biologics Co.,Ltd. Samsung Biologics Co.,Ltd.
Samsung Biologics Co.,Ltd.
207940.KS
 $1.07K -6.40%
KR
UCB S.A. UCB S.A.
UCB S.A.
UCB.BR
 $255.50 13.38%
BE